Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹2,587Cr
Seeds/Tissue Culture/Bio Technology
Rev Gr TTM
Revenue Growth TTM
15.19%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

ROSSARI
VS
| Quarter | Jun 2023 | Sep 2023 | Dec 2023 | Jun 2024 | Sep 2024 | Dec 2024 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | -5.5 | 13.6 | 19.1 | 16.3 | 19.3 | 3.1 | 10.6 | 22.6 | 11.0 | 17.6 | 13.4 | 18.2 |
| 353 | 420 | 400 | 409 | 425 | 432 | 448 | 510 | 476 | 514 | 513 | 608 |
Operating Profit Operating ProfitCr |
| 14.1 | 13.2 | 13.7 | 13.4 | 13.3 | 13.2 | 12.6 | 12.0 | 12.5 | 12.3 | 11.8 | 11.3 |
Other Income Other IncomeCr | 2 | 1 | 4 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 1 | 20 |
Interest Expense Interest ExpenseCr | 6 | 5 | 4 | 3 | 4 | 4 | 5 | 6 | 6 | 6 | 8 | 9 |
Depreciation DepreciationCr | 14 | 15 | 15 | 16 | 15 | 15 | 18 | 18 | 18 | 18 | 20 | 24 |
| 39 | 45 | 48 | 46 | 47 | 48 | 42 | 48 | 46 | 50 | 43 | 64 |
| 10 | 12 | 13 | 11 | 12 | 13 | 11 | 13 | 13 | 13 | 10 | 18 |
|
Growth YoY PAT Growth YoY% | 1.9 | 37.8 | 33.9 | 17.8 | 19.4 | 7.2 | -7.8 | 0.9 | -3.7 | 4.4 | 3.4 | 33.5 |
| 7.1 | 6.8 | 7.4 | 7.2 | 7.1 | 7.1 | 6.2 | 5.9 | 6.2 | 6.3 | 5.6 | 6.7 |
| 5.3 | 6.0 | 6.2 | 6.2 | 6.3 | 6.4 | 5.7 | 6.2 | 6.1 | 6.7 | 5.9 | 8.3 |
| Financial Year | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|
|
| | 16.3 | 18.2 | 109.1 | 11.7 | 10.6 | 13.6 | 15.2 |
| 439 | 495 | 586 | 1,300 | 1,433 | 1,581 | 1,815 | 2,110 |
Operating Profit Operating ProfitCr |
| 15.0 | 17.4 | 17.4 | 12.4 | 13.5 | 13.6 | 12.7 | 11.9 |
Other Income Other IncomeCr | 1 | 4 | 9 | 14 | 6 | 8 | 5 | 24 |
Interest Expense Interest ExpenseCr | 3 | 4 | 3 | 13 | 22 | 19 | 18 | 29 |
Depreciation DepreciationCr | 12 | 17 | 23 | 48 | 63 | 60 | 67 | 79 |
| 63 | 88 | 107 | 136 | 144 | 178 | 185 | 203 |
| 18 | 23 | 27 | 39 | 37 | 47 | 49 | 53 |
|
| | 42.8 | 22.7 | 22.1 | 9.8 | 21.9 | 4.3 | 9.4 |
| 8.8 | 10.9 | 11.3 | 6.6 | 6.5 | 7.1 | 6.6 | 6.2 |
| 9.4 | 13.4 | 15.6 | 17.8 | 19.5 | 23.7 | 24.7 | 26.9 |
| Financial Year | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|
Equity Capital Equity CapitalCr | 4 | 10 | 10 | 11 | 11 | 11 | 11 | 11 |
| 119 | 277 | 398 | 794 | 904 | 1,037 | 1,174 | 1,322 |
Current Liabilities Current LiabilitiesCr | 122 | 149 | 150 | 295 | 349 | 425 | 537 | 790 |
Non Current Liabilities Non Current LiabilitiesCr | 4 | 36 | 2 | 157 | 104 | 100 | 174 | 166 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 160 | 326 | 355 | 609 | 720 | 844 | 1,042 | 1,244 |
Non Current Assets Non Current AssetsCr | 90 | 145 | 207 | 647 | 647 | 729 | 854 | 1,045 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|
Operating Cash Flow Operating Cash FlowCr | 71 | 57 | 48 | 29 | 152 | 43 | 137 | 65 |
Investing Cash Flow Investing Cash FlowCr | -36 | -190 | -37 | -299 | -181 | -103 | -184 | -219 |
Financing Cash Flow Financing Cash FlowCr | -29 | 157 | -25 | 292 | 61 | 16 | 65 | 186 |
|
Free Cash Flow Free Cash FlowCr | 27 | -19 | -8 | -7 | 120 | -83 | -21 | |
| 155.8 | 87.1 | 59.7 | 30.1 | 141.3 | 33.1 | 100.8 | 43.6 |
CFO To EBITDA CFO To EBITDA% | 91.8 | 54.3 | 38.7 | 16.0 | 68.0 | 17.3 | 51.9 | 22.8 |
| Financial Year | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 0 | 0 | 5,388 | 5,030 | 3,284 | 3,726 | 3,344 | 2,095 |
Price To Earnings Price To Earnings | 0.0 | 0.0 | 67.2 | 51.5 | 30.6 | 28.5 | 24.5 | 14.0 |
Price To Sales Price To Sales | 0.0 | 0.0 | 7.6 | 3.4 | 2.0 | 2.0 | 1.6 | 0.9 |
Price To Book Price To Book | 0.0 | 0.0 | 13.2 | 6.3 | 3.6 | 3.6 | 2.8 | 1.6 |
| 0.0 | -0.6 | 42.9 | 27.2 | 14.5 | 15.3 | 13.2 | 8.4 |
Profitability Ratios Profitability Ratios |
| 34.3 | 38.1 | 34.8 | 25.3 | 29.3 | 29.3 | 31.1 | 30.4 |
| 15.0 | 17.4 | 17.4 | 12.4 | 13.5 | 13.6 | 12.7 | 11.9 |
| 8.8 | 10.9 | 11.3 | 6.6 | 6.5 | 7.1 | 6.6 | 6.2 |
| 51.9 | 26.3 | 26.9 | 18.3 | 16.8 | 16.9 | 14.5 | 13.3 |
| 36.9 | 22.8 | 19.6 | 12.1 | 11.7 | 12.5 | 11.5 | 11.2 |
| 18.3 | 13.8 | 14.3 | 7.8 | 7.8 | 8.3 | 7.2 | 6.5 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
#### **Overview**
Rossari Biotech Limited is a leading Indian specialty chemicals manufacturer headquartered in Mumbai, with manufacturing facilities in Silvassa and Dahej, Gujarat. Established in 1997, the company has evolved into a diversified player offering intelligent and sustainable chemical solutions across three core segments:
- **Home, Personal Care & Performance Chemicals (HPPC)**
- **Textile Specialty Chemicals (TSC)**
- **Animal Health and Nutrition (AHN)**
It serves global industries including FMCG, textiles, personal care, agrochemicals, healthcare, pet care, and oil & gas. The company emphasizes innovation, sustainability, and customer-centricity, leveraging over 4,300 products and a robust R&D-driven model.
---
#### **Corporate Leadership & Strategy**
- **Promoters**: Technocrat entrepreneurs with over **45 years of combined experience** in the specialty chemicals industry.
- **Growth Pillars**: Diversification, globalization, innovation, and capacity enhancement.
- **Strategic Focus**:
- Developing green chemistry and sustainable solutions (e.g., biosurfactants, enzyme-based formulations, NMMO).
- Expanding into high-growth segments like spin finish, technical textiles, pet food, vitamin premixes, and oil & gas.
- Increasing wallet share through cross-selling to MNC customers and expanding into new geographies.
- Pursuing inorganic growth via acquisitions and joint ventures.
---
#### **Business Segments Overview**
1. **Home, Personal Care & Performance Chemicals (HPPC)**
- Core products: Surfactants, phenoxyethanol, esters, acrylic polymers, institutional hygiene solutions.
- Key drivers: Demand in agrochemicals, personal care, and institutional cleaning.
- Achieved **16.2% YoY growth**, added **93 new customers**, and expanded into 14 new geographies.
- Developed green surfactants and biosurfactants using fermentation technology.
- Launched **Dr. Nanoxa**, a nanotechnology-based antimicrobial coating with 30-day protection.
- Commissions new ethoxylation capacities and expands capacity for phenoxypropanol and polyethylene glycol (PEG) powders.
2. **Textile Specialty Chemicals (TSC)**
- India’s **largest manufacturer** of textile specialty chemicals.
- Provides eco-friendly solutions across the entire value chain—from fiber production to garment finishing.
- Offers functional finishes: antimicrobial, UV protection, water repellence, wrinkle resistance.
- Innovations: Sustainable black dyeing process, enzyme-based scouring (RENEWA initiative), water-less dyeing tech.
- Textile revenue grew **14% YoY**, driven by exports; domestic growth at 5–6%.
- Expanding into spin finishes, textile sizing, and silicon-based lubricants.
- Strong presence in export markets: Egypt, Bangladesh, Southeast Asia, North Africa.
3. **Animal Health & Nutrition (AHN)**
- Established over 13 years ago; now a strategic growth vertical.
- Offers over **100 products**: vitamin premixes, enzymes, acidifiers, gut health solutions.
- Serves poultry, aqua feed, dairy, and pet care sectors.
- Launched pet care brands: **Lozalo** (grooming), **Zippy** (pet food), **Top Tail** (feline food).
- Entering therapeutic and gut health segments using bioprocess technology.
- Plans to build a vitamin premix and mineral production facility.
- Focused on exports to Bangladesh, Nepal, Sri Lanka, and Latin America.
---
#### **Global Expansion & Distribution**
- Serves **over 1,000 clients** globally across 25+ countries.
- Long-standing client relationships (some exceeding **15 years**).
- Export revenue now accounts for **28%** of total revenue (up from 24% in FY24), growing **36% YoY** in Q2 FY26.
- **Key international markets**:
- **Southeast Asia**: Indonesia, Thailand, Vietnam, Cambodia
- **Middle East & Africa**: Egypt, Saudi Arabia, UAE, Turkey
- **Americas**: Brazil, Peru, Colombia, USA, Russia
- **Europe**: Germany, Belgium, Italy
- Strategic investments:
- Subsidiary **Rossari International Limited** established in **Saudi Arabia** ($8 million approved investment).
- **Overseas formulation hub** being set up in **Thailand**.
- Joint ventures: **Hextar Unitop (Malaysia)**, **Romakk Chemicals (India)**.
- Export offices in **Vietnam, Thailand, Turkey, and Dubai**.
---
#### **Manufacturing & Capacity**
- Operates **7 manufacturing facilities** with a total installed capacity of **367,100 MTPA** (as of Oct 2025), up from 332,100 MTPA earlier.
- Key sites:
- **Dahej (I & II)**: 132,500 MTPA, near port for logistics advantage; includes 500 kW solar plant.
- **Silvassa**: 120,000 MTPA, fully automated, zero liquid discharge.
- Acquired capacities from **Unitop Chemicals** (64,000 MTPA) and **Tristar Intermediates** (15,000 MTPA).
- **Capacity Expansion (FY25–FY26)**:
- **20,000 MTPA** new capacity at Dahej.
- **15,000 MTPA** ethoxylation expansion at Unitop.
- **30,000 MTPA** ethoxylation capacity added to meet demand in agrochemicals, home & personal care, oil & gas, and pharma.
- Backward integration:
- In-house production of **surfactants**, **silicon oils**, **phenoxyethanol**, **sorbitan esters**, **choline chloride**, and **NMMO**.
---
#### **Innovation & R&D**
- **Four core chemistries**: Surfactants, Silicones, Acrylics, Enzymes.
- Operates **four R&D centers** in Mumbai, Silvassa, and Dahej.
- **Rossari Centre of Excellence** established at **IIT Bombay** (recognized by DSIR).
- Over **140 new products launched** in recent years, ~18% of revenue from new products.
- Focus on green chemistry: biosurfactants (Sophorolipids), bio-softeners, low-temperature processing, enzyme-based desizing.
- Key innovations:
- **Renewa**: Green platform for sustainable towel processing.
- **Ester Quartz**: Renewable-based softener.
- **Dr. Nanoxa**: Nano-antimicrobial surface coating.
- **Phenoxy Propanol**: Next-gen preservative for personal care.
- **PEG Powder**: Entry into pharmaceutical tablet coatings.
- **NMMO**: Solvent for eco-friendly Lyocell fiber manufacturing.
---
#### **Key Acquisitions & Subsidiaries (Strategic Integration)**
Rossari has strengthened its portfolio through strategic acquisitions completed since 2021:
| Subsidiary | Focus | Capacity | Key Highlights |
|-----------|-------|--------|----------------|
| **Unitop Chemicals Pvt. Ltd. (UCPL)** | Surfactants, Emulsifiers, Agrochemicals | 86,000 MTPA (as of 2023), now 64,000 MTPA post-realignment | Strong presence in 25+ countries; 50% JV with Hextar (Malaysia); key in phenoxy series and ethoxylation tech |
| **Tristar Intermediates Private Ltd.** | Preservatives, Aroma Chemicals, Distillation Tech | 15,000 MTPA | Supplies MNCs; expertise in phenoxyethanol, propoxylation; key in pharma intermediates |
| **Romakk Chemicals Pvt. Ltd.** | Silicone Oils, Emulsions, Lubricants | 600 MTPA | JV with McCoy & KK Chemicals; enables in-house silicon oil production |
| **Buzil Rossari / Rossari Professional** | Institutional Cleaning & Hygiene | — | Rebranded; offers bundled hygiene solutions; Rs. 200 crore revenue (9MFY25) |
| **Rossari Global DMCC** (UAE) | Export trading hub | — | Manages global sales via Jebel Ali Free Zone |
| **Unistar Thai Co. Ltd.** (Thailand) | New manufacturing entity | — | Future expansion in Southeast Asia |
| **Rossari Bangladesh** | Local entity for textile market | — | Strengthening footprint in largest export market |
- Full ownership of Unitop and Tristar achieved by mid-2024.
- Synergies: Cross-selling, shared tech platforms, integrated R&D, and unified go-to-market strategies.
---
#### **Financial & Operational Performance**
- **Revenue CAGR (FY19–FY25)**: **26%**
- **PAT CAGR (FY19–FY25)**: **20%**
- **Revenue Growth (FY25)**: **13.6%**, driven by HPPC, AHN, and new consumer verticals.
- **New Verticals Performance** (Institutional Cleaning, B2C Hygiene):
- Revenue: **₹300 crore**, up **67% YoY**.
- Institutional cleaning business: Grew to **₹200 crore** in 9MFY25.
- **Strong EBITDA and Margin Trends**:
- Consolidated gross margins improved YoY.
- Record-high EBITDA reported in FY25.
- Margin pressure expected to ease as new capacities ramp up and operating leverage improves.
---
#### **Competitive Positioning**
- **Competes with global players** like Dow, BASF, Croda, Solvay, Archroma, Huntsman, Ecolab, and Diversey.
- **Differentiators**:
- Agile, fungible manufacturing.
- Deep R&D and customization.
- Sustainable, green chemical solutions.
- Integrated supply chain and backward integration.
- Localized production with global outreach.
---